Last 12 months
Inside the activity.
2 purchase rows · 112 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 26 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 56 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2021 Filed Feb 11, 2021 23:47 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
GrantCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005284 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,739 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:51 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
GrantPerformance Shares · Derivative | 4,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005285 · form4.xml · derivative · entry 2 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,967 Underlying: Common Stock · 4,967 shares Expires 2023-12-31 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:51 UTC |
RAGUSA ROBERT PSVP, Global Quality & Ops
|
GrantCommon Stock | 1,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005285 · form4.xml · nonDerivative · entry 1 RAGUSA ROBERT P · CIK 0001222644 · SVP, Global Quality & Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,795 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 47 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:45 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
GrantPerformance Shares · Derivative | 4,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005283 · form4.xml · derivative · entry 2 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,140 Underlying: Common Stock · 4,140 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:45 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
GrantCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005283 · form4.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,112 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:44 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
GrantPerformance Shares · Derivative | 4,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005282 · form4.xml · derivative · entry 2 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,140 Underlying: Common Stock · 4,140 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:44 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
GrantCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005282 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,523 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:42 UTC |
Dadswell CharlesSVP & General Counsel
|
GrantPerformance Shares · Derivative | 4,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005281 · form4.xml · derivative · entry 2 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,140 Underlying: Common Stock · 4,140 shares Expires 2023-12-31 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:42 UTC |
Dadswell CharlesSVP & General Counsel
|
GrantCommon Stock | 1,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005281 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,892 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 52 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:40 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
GrantPerformance Shares · Derivative | 6,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005280 · form4.xml · derivative · entry 2 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,623 Underlying: Common Stock · 6,623 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 23:40 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
GrantCommon Stock | 2,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005280 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,503 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:48 UTC |
TOUSI SUSAN HSVP Product Development
|
SaleCommon Stock | 800 | $431.90 | $345,520.00 |
DisclosureSEC source: 0001127602-21-004731 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,713 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · balance_after: Balance includes 66 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 22:00 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 57 | $444.84 | $25,355.88 |
DisclosureSEC source: 0001127602-21-003735 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,359 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · balance_after: Balance includes 57 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 21:57 UTC |
MCGINNIS KAREN KVP, Chief Accounting Officer
|
SaleCommon Stock | 72 | $444.84 | $32,028.48 |
DisclosureSEC source: 0001127602-21-003732 · form4.xml · nonDerivative · entry 1 MCGINNIS KAREN K · CIK 0001188264 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,538 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · balance_after: Balance includes 72 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 21:58 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $444.84 | $1,779,360.00 |
DisclosureSEC source: 0001127602-21-003733 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 85 | $445.64 | $37,879.40 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 12 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,603 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F14 · price: Weighted average sale price representing 85 shares sold ranging from $445.52 to $445.92 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 128 | $444.81 | $56,935.68 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 11 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,688 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F13 · price: Weighted average sale price representing 128 shares sold ranging from $444.45 to $445.31 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 194 | $443.71 | $86,079.74 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 10 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,816 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F12 · price: Weighted average sale price representing 194 shares sold ranging from $443.43 to $443.97 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 245 | $442.74 | $108,471.30 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 9 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,010 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F11 · price: Weighted average sale price representing 245 shares sold ranging from $442.32 to $443.31 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 701 | $441.71 | $309,638.71 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 8 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,255 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F10 · price: Weighted average sale price representing 701 shares sold ranging from $441.25 to $442.17 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 447 | $440.63 | $196,961.61 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 7 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,956 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F9 · price: Weighted average sale price representing 447 shares sold ranging from $440.03 to $441.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 323 | $439.10 | $141,829.30 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 6 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,403 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F8 · price: Weighted average sale price representing 323 shares sold ranging from $438.82 to $439.54 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 128 | $437.66 | $56,020.48 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 5 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,726 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F7 · price: Weighted average sale price representing 128 shares sold ranging from $437.44 to $437.88 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 174 | $436.47 | $75,945.78 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 4 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,854 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 174 shares sold ranging from $436.20 to $437 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 306 | $435.52 | $133,269.12 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,028 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 306 shares sold ranging from $435.16 to $436.07 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 91 | $433.98 | $39,492.18 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,334 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 91 shares sold ranging from $433.95 to $434.03 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:56 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 178 | $431.50 | $76,807.00 |
DisclosureSEC source: 0001127602-21-003730 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,425 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 178 shares sold ranging from $431.41 to $431.65 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. F3 · balance_after: Balance includes 63 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| January 20, 2021 Filed Jan 21, 2021 21:40 UTC |
TOUSI SUSAN HSVP Product Development
|
SaleCommon Stock | 2,500 | $400.00 | $1,000,000.00 |
DisclosureSEC source: 0001127602-21-002268 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,447 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 21:38 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $382.48 | $1,529,920.00 |
DisclosureSEC source: 0001127602-21-002267 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 11, 2021 Filed Jan 12, 2021 21:41 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 271 | $379.65 | $102,885.15 |
DisclosureSEC source: 0001127602-21-001519 · form4.xml · nonDerivative · entry 2 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,359 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:41 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
Tax withholdingCommon Stock | 114 | $379.61 | $43,275.54 |
DisclosureSEC source: 0001127602-21-001519 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,630 Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 22:51 UTC |
SAMAD SAMSVP and CFO
|
Tax withholdingCommon Stock | 214 | $376.55 | $80,581.70 |
DisclosureSEC source: 0001127602-21-001215 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,114 Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 00:20 UTC |
TOUSI SUSAN HSVP Product Development
|
SaleCommon Stock | 300 | $365.27 | $109,581.00 |
DisclosureSEC source: 0001127602-21-001150 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,947 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 00:19 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $365.27 | $1,461,080.00 |
DisclosureSEC source: 0001127602-21-001149 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:17 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 73 | $374.01 | $27,302.73 |
DisclosureSEC source: 0001127602-21-001146 · form4.xml · nonDerivative · entry 8 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,540 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F9 · price: Weighted average sale price representing 73 shares sold ranging from $374 to $374.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:17 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 234 | $373.11 | $87,307.74 |
DisclosureSEC source: 0001127602-21-001146 · form4.xml · nonDerivative · entry 7 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,613 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F8 · price: Weighted average sale price representing 234 shares sold ranging from $372.88 to $373.46 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:17 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 582 | $372.07 | $216,544.74 |
DisclosureSEC source: 0001127602-21-001146 · form4.xml · nonDerivative · entry 6 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,847 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F7 · price: Weighted average sale price representing 582 shares sold ranging from $371.72 to $372.66 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:17 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 921 | $371.18 | $341,856.78 |
DisclosureSEC source: 0001127602-21-001146 · form4.xml · nonDerivative · entry 5 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,429 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 921 shares sold ranging from $370.68 to $371.65 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:17 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 416 | $370.29 | $154,040.64 |
DisclosureSEC source: 0001127602-21-001146 · form4.xml · nonDerivative · entry 4 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,350 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 416 shares sold ranging from $369.65 to $370.63 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:17 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 167 | $368.84 | $61,596.28 |
DisclosureSEC source: 0001127602-21-001146 · form4.xml · nonDerivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,766 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 167 shares sold ranging from $368.51 to $369.48 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:17 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 238 | $367.75 | $87,524.50 |
DisclosureSEC source: 0001127602-21-001146 · form4.xml · nonDerivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 238 shares sold ranging from $367.40 to $368.09 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:17 UTC |
deSouza Francis ADirector · President and CEO
|
SaleCommon Stock | 369 | $366.84 | $135,363.96 |
DisclosureSEC source: 0001127602-21-001146 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,171 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 369 shares sold ranging from $366.38 to $367.37 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| December 23, 2020 Filed Dec 30, 2020 21:25 UTC |
ARNOLD FRANCESDirector
|
OtherCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-032559 · form4.xml · nonDerivative · entry 1 ARNOLD FRANCES · CIK 0001665419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,927 F1 · shares: Represents shares inherited from grandparents. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 23:07 UTC |
FLATLEY JAY TDirector
|
SaleCommon Stock | 4,000 | $348.84 | $1,395,360.00 |
DisclosureSEC source: 0001127602-20-031603 · form4.xml · nonDerivative · entry 1 FLATLEY JAY T · CIK 0001189130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,933 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 23:05 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 354 | $345.00 | $122,130.00 |
DisclosureSEC source: 0001127602-20-031600 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,744 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:12 UTC |
Ronaghi MostafaSVP, Entrepreneurial Devlopmt
|
SaleCommon Stock | 400 | $341.00 | $136,400.00 |
DisclosureSEC source: 0001127602-20-031257 · form4.xml · nonDerivative · entry 4 Ronaghi Mostafa · CIK 0001441876 · SVP, Entrepreneurial Devlopmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,162 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:12 UTC |
Ronaghi MostafaSVP, Entrepreneurial Devlopmt
|
SaleCommon Stock | 2,200 | $339.42 | $746,729.06 |
DisclosureSEC source: 0001127602-20-031257 · form4.xml · nonDerivative · entry 3 Ronaghi Mostafa · CIK 0001441876 · SVP, Entrepreneurial Devlopmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,562 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 2,200 shares sold ranging from $339.1100 to $339.9900 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:12 UTC |
Ronaghi MostafaSVP, Entrepreneurial Devlopmt
|
SaleCommon Stock | 1,100 | $337.99 | $371,790.87 |
DisclosureSEC source: 0001127602-20-031257 · form4.xml · nonDerivative · entry 2 Ronaghi Mostafa · CIK 0001441876 · SVP, Entrepreneurial Devlopmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,762 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 1,100 shares sold ranging from $337.8000 to $338.4450 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:12 UTC |
Ronaghi MostafaSVP, Entrepreneurial Devlopmt
|
SaleCommon Stock | 1,300 | $336.92 | $438,002.11 |
DisclosureSEC source: 0001127602-20-031257 · form4.xml · nonDerivative · entry 1 Ronaghi Mostafa · CIK 0001441876 · SVP, Entrepreneurial Devlopmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,862 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 1,300 shares sold ranging from $336.2100 to $337.0850 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| December 07, 2020 Filed Dec 8, 2020 22:34 UTC |
TOUSI SUSAN HSVP Product Development
|
SaleCommon Stock | 200 | $350.00 | $70,000.00 |
DisclosureSEC source: 0001127602-20-030884 · form4.xml · nonDerivative · entry 3 TOUSI SUSAN H · CIK 0001791938 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,247 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.